Michael Foster, MD
Interventional Cardiology · Columbia, SCNPI 1780625269
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (38.0%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Shockwave Medical, Inc at 37.5% of the total. Reporting peaked in 2023 at $9,327 and has fallen 60.6% since, to $3,679 in 2025.
Across 238 payments — averaging $95.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$9K
- Medtronic$7K
- Boston Scientific$3K
- Abiomed$752
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$497
- Novartis$433
- plus $2K from 27 others
Across 10 payments — averaging $5124.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$32K
- Abbott$19K
What the payments were for
- Speaking & faculty fees$6,60029%
- Travel & lodging$7,54133%
- Food & beverage$8,66638%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 12 | $8,554 |
| Medtronic(2 entities) | 40 | $6,649 |
| Boston Scientific | 37 | $3,438 |
| Abiomed | 14 | $752 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $497 |
| Novartis | 35 | $433 |
| AstraZeneca | 17 | $306 |
| Amgen | 15 | $263 |
| Teleflex LLC | 3 | $228 |
| Johnson & Johnson | 7 | $203 |
| Recor Medical Inc | 3 | $188 |
| Edwards Lifesciences | 1 | $139 |
| Cardiva Medical, Inc. | 6 | $139 |
| Cvrx, Inc. | 1 | $137 |
| Lilly USA, LLC | 1 | $107 |
| Abbott | 4 | $106 |
| Pfizer | 4 | $83 |
| Philips North America LLC | 2 | $79 |
| Cardinal Health 200 LLC | 5 | $68 |
| Merck | 2 | $63 |
| Inari Medical, Inc. | 1 | $62 |
| E.r. Squibb & Sons, L.L.C. | 3 | $45 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 1 | $42 |
| Penumbra, Inc. | 2 | $41 |
| Grifols USA, LLC | 1 | $39 |
| Irhythm Technologies, Inc. | 1 | $25 |
| Livanova USA, Inc. | 1 | $21 |
| Cardiovascular Systems Inc. | 2 | $19 |
| Novo Nordisk | 1 | $19 |
| Cordis US CORP. | 1 | $19 |
| Terumo Medical Corporation | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Chiesi USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$8,318
- Resolute$4,470
- SYMPLICITY G3$1,188
- AVVIGO Guidance System$733
- LOTUS EDGE$654
- COREVALVE EVOLUT R$298
- LifeVest$245
- GENERAL - STRUCTURAL HEART$237
- GENERAL ATHERECTOMY$174
- Paradise Ultrasound Renal Denervation System$143
- SAPIEN 3 Ultra RESILIA$139
- Barostim Neo System$137
- OPTICROSS$135
- TURNPIKE$130
- FIGHTER$124
- XARELTO$117
- ZEPBOUND$107
- GENERAL - STENTS$103
- FARXIGA$102
How this compares
$22,807 in reported general payments places this provider in the 75th percentile of 117 interventional cardiology providers in South Carolina.
See all interventional cardiology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 239 | $253,257 |
| EntrestoSacubitril/Valsartan | 138 | $165,296 |
| Repatha SureclickEvolocumab | 93 | $99,512 |
| JardianceEmpagliflozin | 106 | $95,894 |
| XareltoRivaroxaban | 87 | $78,407 |
| FarxigaDapagliflozin Propanediol | 63 | $64,593 |
| Praluent PenAlirocumab | 26 | $23,933 |
| MultaqDronedarone Hcl | 16 | $17,987 |
| OzempicSemaglutide | 18 | $17,011 |
| BrilintaTicagrelor | 24 | $12,187 |
| EdarbyclorAzilsartan Med/Chlorthalidone | 25 | $9,590 |
| VascepaIcosapent Ethyl | 16 | $8,530 |
| Metoprolol Succinate | 438 | $6,492 |
| Rosuvastatin Calcium | 345 | $5,789 |
| Atorvastatin Calcium | 322 | $4,769 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $83 | $253,257239 claims |
| NovartisEntresto | $433 | $165,296138 claims |
| Johnson & JohnsonXarelto | $203 | $78,40787 claims |
| AstraZenecaFarxiga, Brilinta | $306 | $76,78087 claims |
| Sanofi-aventis U.S. LLCMultaq | $15 | $17,98716 claims |
| Novo NordiskOzempic | $19 | $17,01118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 117 interventional cardiology providers in South Carolina.
Other interventional cardiology in Columbia
- Michael CryerColumbia$92K
- Loren MorganColumbia$60K
- Vince VismaraColumbia$60K
- Patrick HallColumbia$50K
- George YankeyColumbia$41K
- Matthew CantrellColumbia$21K
- Christopher HuffmanColumbia$21K
- Gopi ShahColumbia$16K
- Katrina BidwellColumbia$15K
- Guillermo PinedaColumbia$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.